{
  "name": "Rinascera Therapeutics",
  "short_name": "Rinascera",
  "description": "Rinascera Therapeutics develops transformative therapies for rare genetic skin diseases, including RIN-001 for Gorlin Syndrome and RIN-002 for Dystrophic Epidermolysis Bullosa (DEB).",
  "start_url": "/",
  "display": "standalone",
  "background_color": "#ffffff",
  "theme_color": "#1A5963",
  "icons": [
    {
      "src": "https://media.base44.com/images/public/696ff2c291c3c012a0f2adfa/39c599e85_image.png",
      "sizes": "192x192",
      "type": "image/png"
    },
    {
      "src": "https://media.base44.com/images/public/696ff2c291c3c012a0f2adfa/39c599e85_image.png",
      "sizes": "512x512",
      "type": "image/png"
    }
  ]
}